BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37075481)

  • 1. Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population.
    Anand A; Kumar R; Sharma S; Gupta A; Vijayvergiya R; Mehrotra S; Kumar B; Lad D; Patil AN; Shafiq N; Malhotra S
    Drug Metab Pers Ther; 2023 Sep; 38(3):273-279. PubMed ID: 37075481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
    Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
    Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
    Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
    Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.
    Krishna Kumar D; Shewade DG; Loriot MA; Beaune P; Balachander J; Sai Chandran BV; Adithan C
    Eur J Clin Pharmacol; 2014 Jan; 70(1):47-56. PubMed ID: 24019055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.
    Sagreiya H; Berube C; Wen A; Ramakrishnan R; Mir A; Hamilton A; Altman RB
    Pharmacogenet Genomics; 2010 Jul; 20(7):407-13. PubMed ID: 20442691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation.
    Xu Q; Xu B; Zhang Y; Yang J; Gao L; Zhang Y; Wang H; Lu C; Zhao Y; Yin T
    Thromb Haemost; 2012 Dec; 108(6):1132-40. PubMed ID: 23015069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation.
    Wei M; Ye F; Xie D; Zhu Y; Zhu J; Tao Y; Yu F
    Thromb Haemost; 2012 Jun; 107(6):1083-91. PubMed ID: 22534826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.
    Dietz N; Ruff C; Giugliano RP; Mercuri MF; Antman EM
    Int J Cardiol; 2020 Oct; 317():159-166. PubMed ID: 32505370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
    Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ
    Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.
    You JH; Wong RS; Waye MM; Mu Y; Lim CK; Choi KC; Cheng G
    J Thromb Thrombolysis; 2011 Jan; 31(1):113-8. PubMed ID: 20585834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients.
    Deng J; Wang Y; An X
    J Clin Pharmacol; 2023 May; 63(5):569-582. PubMed ID: 36546564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.
    Cini M; Legnani C; Cosmi B; Guazzaloca G; Valdrè L; Frascaro M; Palareti G
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1167-74. PubMed ID: 22349464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
    Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
    Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
    Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
    Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
    Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
    J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
    Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
    J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study.
    Zambon CF; Pengo V; Padrini R; Basso D; Schiavon S; Fogar P; Nisi A; Frigo AC; Moz S; Pelloso M; Plebani M
    Pharmacogenomics; 2011 Jan; 12(1):15-25. PubMed ID: 21174619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients.
    Sasano M; Ohno M; Fukuda Y; Nonen S; Hirobe S; Maeda S; Miwa Y; Yokoyama J; Nakayama H; Miyagawa S; Sawa Y; Fujio Y; Maeda M
    Eur J Clin Pharmacol; 2019 Jul; 75(7):901-911. PubMed ID: 30852642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.
    Liang R; Li L; Li C; Gao Y; Liu W; Hu D; Sun Y
    J Thromb Thrombolysis; 2012 Jul; 34(1):120-5. PubMed ID: 22528326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
    Johnson JA; Caudle KE; Gong L; Whirl-Carrillo M; Stein CM; Scott SA; Lee MT; Gage BF; Kimmel SE; Perera MA; Anderson JL; Pirmohamed M; Klein TE; Limdi NA; Cavallari LH; Wadelius M
    Clin Pharmacol Ther; 2017 Sep; 102(3):397-404. PubMed ID: 28198005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.